drugset / Trial / NCT01532115

Effect of BIA 9-1067 on Cardiac Repolarization in Healthy Adult Men and Women

NCT01532115

Phase 1 Completed 64 enrolled Bial - Portela C S.A.
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effect of BIA 9-1067 on the cardiac repolarization in adult healthy men and women volunteers.

Timeline

Start
2010-05
Primary completion
2010-10
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Moxifloxacin Small molecule 400 mg
Subject Opicapone Small molecule 50 mg
Subject Opicapone Small molecule 800 mg

Indications